Risk factors associated with life-threatening infections in children with febrile neutropenia: A data mining approach

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 1, 2011, Pages

  Badiei, Zahra ^a   Khalesi, Maryam ^b   Alami, Mohammad Hasan ^c   Kianifar, Hamid Reza ^b   Banihashem, Abdollah ^a   Farhangi, Hamid ^a   Razavi, Amir Reza ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Ghaem Medical Center   (Iran)

^c Department of Pediatric Infectious Disease   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

children; decision tree induction; Febrile neutropenia; life threatening infection

Indexed keywords

ARTICLE; BODY TEMPERATURE; CHILD; DATA MINING; DECISION TREE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPHIL COUNT; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY; THROMBOCYTE COUNT;

CHILD; CROSS-SECTIONAL STUDIES; DATA MINING; FEMALE; FEVER; HUMANS; INFECTION; MALE; NEUTROPENIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 78650777931     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181f6921a     Document Type: Article

References (22)

1. Klaassen RJ, Goodman TR, Pham B, et al. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012-1019.
2. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19:3415-3421.
3. Yoo JH, Choi SM, Lee DG, et al. Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea. J Korean Med Sci. 2005;20:31-35.
4. Cherif H, Johansson E, Bjorkholm M, et al. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies. Haematologica. 2006;91:215-222.
5. Lanzkowsky P. Manual of Pediatric Hematology and Oncology. 4th ed. Amesterdam: Elsevier; Churchill Livingstone; 2005:70.
6. Moores K. Safe and effective outpatient treatment of adults with chemotherapy-induced neutropenic fever. Am J Health Syst Pharm. 2007;64:717-722.
7. Santolaya ME, Alvarez AM, Aviles CL, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis. 2002;35:678-683.
8. Sebban C, Dussart S, Fuhrmann C, et al. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge. Support Care Cancer. 2008;16:1017-1023.
9. Klastersky J, Paesmans M, Rubenstein EB, et al. The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038-3051.
10. Santolaya ME, Alvarez AM, Aviles CL, et al. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. J Clin Oncol. 2004;22: 3784-3789.
11. Santolaya ME, Alvarez AM, Aviles CL, et al. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode. Pediatr Infect Dis J. 2007;26:794-798.
12. Gean-bancloche JC, Walsh T. Infections in the cancer patient. In: Devita VT, Segal BH, Hellman S, et al. eds. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005;2486-2495.
13. Rennie TW, Roberts W. Data mining of tuberculosis patient data using multiple correspondence analysis. Epidemiol Infect. 2009;137:1699-1704.
14. Razavi AR, Gill H, Ahlfeldt H, et al. Non-compliance with a postmastectomy radiotherapy guideline: Decision tree and cause analysis. BMC Med Inform Decis Mak. 2008;8:41.
15. Hann I, Viscoli C, Paesmans M, et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four (EORTC) studies. Therapy Cooperative Group (IATCG) of the European Organization International Antimicrobial for Research and Treatment of Cancer (EORTC). Br J Haematol. 1997;99: 580-588.
16. Rondinelli PI, Ribeiro Kde C, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol. 2006;28:665-670.
17. Quinlan JR. C4.5: Programs for Machine Learning. San Mateo, CA: Morgan Kaufmann; 1993:591-599.
18. Razavi AR, Gill H, Ahlfeldt H, et al. Predicting metastasis in breast cancer: Comparing a decision tree with domain experts. J Med Syst. 2007;31:263-273.
19. Raisch DW, Holdsworth MT, Winter SS, et al. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children. Value Health. 2003;6:158-166.
20. Walsh T, Roilides E, Groll A, et al. Infectious complications in pediatric cancer patients. In: Pizzo P, Poplack D, eds. Principles and Practice of Pediatric Oncology. 5 ed. Philadelphia: Lippincott Williams & Wilkins; 2006:p1290.
21. Ammann RA, Hirt A, Luthy AR, et al. Identification of children presenting with fever in chemotherapy induced neutropenia at low risk for sever bacterial infection. Med Pediatr Oncol. 2003; 41:436-443.
22. Paganini HR, Aguirre C, Puppa G, et al. A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer. Cancer. 2007;109: 2572-2579.